Sort by
Refine Your Search
-
Listed
-
Employer
- Delft University of Technology (TU Delft)
- Maastricht University (UM)
- Wageningen University & Research
- Utrecht University
- Vrije Universiteit Amsterdam (VU)
- Amsterdam UMC
- University of Amsterdam (UvA)
- Delft University of Technology
- Eindhoven University of Technology (TU/e)
- Erasmus MC (University Medical Center Rotterdam)
- Leiden University
- Royal Netherlands Academy of Arts and Sciences (KNAW)
- Sanquin Blood Supply Foundation (Sanquin)
- TU Delft
- 4 more »
- « less
-
Field
-
to support pandemic risk assessment and antiviral strategies. Where to apply Website https://www.academictransfer.com/en/jobs/363519/phd-position-in-virus-glycan-in… Requirements Specific Requirements We
-
project, an interdisciplinary and transdisciplinary research project funded by NWO, the Netherlands Research Council, under the call on KIC Consumer behaviour for a circular system transition. See: https
-
research is embedded within the chair of Operations Research and Logistics ( https://www.wur.nl/en/chair-groups/business-science/operations-research-and-logistics ), which is led by Prof. Sander De Leeuw
-
, TU Delft conducts a risk assessment during the recruitment of personnel. We do this, among other things, to prevent the unwanted … Where to apply Website https://www.academictransfer.com/en/jobs/363721
-
, decision) and contexts (exposure to different hazards, or institutional and cultural factors). This limited knowledge hinders a full understanding of societal progress on adaptation worldwide, and in Europe
-
Requirements . Please note: You can apply online. We will not process applications sent by email and/or post. As part of knowledge security, TU Delft conducts a risk assessment during the recruitment
-
to develop a novel universal therapy for maintaining hemostasis in patients at risk for bleeding. Objectives Computational de novo design of VHH and scFv binders to blood coagulation factors such as factor Xa
-
Economics (BEC) group ; and Dr Raimon Ripoll-Bosch from the Animal Production Systems (APS) group of Wageningen University & Research. The work of Prof. dr Miranda Meuwissen focuses on farm economics, risk
-
Health Data Sciences and Informatics (OHDSI, https://ohdsi-europe.org ) initiative, dedicated to bring out the full value of observational health data through the OMOP Common Data Model and large-scale
-
concept for integrating human variability into next‑generation in vitro safety testing. The knowledge generated will contribute to more accurate risk estimation and support the development of chemical